Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome
Provided By GlobeNewswire
Last update: Mar 17, 2025
Humanetics’ Novel Radioprotective Agent Being Developed with Funding from Department of Defense as Radiation Medical Countermeasure (MCM)
Lifecore to Carry Out Tech Transfer and Analytical Method Activities, including Filling of Pilot Batch
Read more at globenewswire.com
